The Department fully understands that maintaining access to dry eye medications is vitally important to many people in this country.
We are aware that, due to long term manufacturing issues experienced by the sole supplier, Lacri-Lube Eye ointment has not been available since 2018.
We have liaised with the Royal College of Ophthalmologists who has issued advice for clinicians regarding suitable alternative treatments to manage affected patients during this time. We have also communicated the supply issue with the National Health Service and supplies of Lacri-Lube are expected to become available at the end of this year.
We continue to work closely with industry and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.